← All trials
NCT06029309
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2024
- Primary completion
- Jan 31, 2028
- Completion date
- Jan 31, 2032
- First posted
- Sep 8, 2023
- Last posted
- Nov 22, 2023
- Enrollment
- 27
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of MiamiLead sponsor
- IncyteCollaborator
- MorphoSysCollaborator
- BeOne MedicinesCollaborator
- University of MiamiOverall official - principal investigator
- University of MiamiSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.